Chordate Medical Holding
15.4
SEK
-12.5 %
CMH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 following
-12.5%
-35.83%
-34.47%
-40.54%
-74.72%
-83.75%
-95.96%
-92.83%
-99.2%
www.chordate.com/investor-relations
Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked a nerve-modulating treatment technique for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (KOS). The company sells its products to treating clinics in selected European markets, Israel and Saudi Arabia, with the aim of increasing its presence in the global market.
Revenue
980K
EBIT %
-3,017.35 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CMH
Daily low / high price
15.4 / 17.9
SEK
Market cap
17.07M SEK
Turnover
134.27K SEK
Volume
8K
Financial calendar
Annual report
2025-02-28
General meeting
2025-05-21
Interim report
2025-05-23
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Lars Ingvarsson inkl bolag | 12.2 % | 12.2 % |
| Hawoc Investment AB | 9.1 % | 9.1 % |
| Isak Brandberg AB med närstående | 8.2 % | 8.2 % |
| Tommy Hedberg | 7.6 % | 7.6 % |
| Tor-Björn Bengtsson | 4.5 % | 4.5 % |
| Carsten Johansen | 2.5 % | 2.5 % |
| Nordnet Pensionsförsäkring AB | 2.2 % | 2.2 % |
| David Nyman | 2.0 % | 2.0 % |
| Conny Holmström | 1.4 % | 1.4 % |
| Henrik Rammer | 1.4 % | 1.4 % |
ShowingAll content types
Chordate Medical Holding AB (publ) announces the outcome of warrants of series TO 8
Sista dag för handel med teckningsoptioner av serie TO 8 i Chordate Medical Holding AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools